20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-κB in RAW 264.7 macrophages stimulated with lipopolysaccharide
- 8 March 2004
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 205 (1), 23-29
- https://doi.org/10.1016/j.canlet.2003.09.037
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compoundsMutation research. Reviews in mutation research, 2003
- Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomasBiochemical and Biophysical Research Communications, 2002
- Role of cyclooxygenase‐2 and inducible nitric oxide synthase in pancreatic cancerJournal of Gastroenterology and Hepatology, 2002
- The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell lineHepatology, 2002
- Up-Regulation of Cyclooxygenase-2 Expression in Lymphocytic Thyroiditis and Thyroid TumorsAmerican Journal of Clinical Pathology, 2002
- Prevention of Growth and Metastasis of Murine Melanoma through Enhanced Natural-Killer Cytotoxicity by Fatty Acid-Conjugate of Protopanaxatriol.Biological & Pharmaceutical Bulletin, 2002
- Interaction Between Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Gastric CancerJournal of Clinical Gastroenterology, 2001
- Role of nitric oxide in carcinogenesis and tumour progressionThe Lancet Oncology, 2001
- Ginseng pharmacology: Multiple constituents and multiple actionsBiochemical Pharmacology, 1999
- Main Ginseng Saponin Metabolites Formed by Intestinal BacteriaPlanta Medica, 1996